Skip Navigation
Menu
Ideas and Opinions |1 November 2016

Getting to Lower Systolic Blood Pressure: Beyond Antihypertensive Therapy

Nadia A. Khan, MD, MSc

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
This article was published at www.annals.org on 16 August 2016.
  • From University of British Columbia, Vancouver, British Columbia, Canada.

    Disclosures: The author has disclosed no conflicts of interest. The form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M16-1421.

    Corresponding Author: Nadia A. Khan, University of British Columbia, Center for Health Evaluation and Outcomes Sciences, 570.4B, 1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada; e-mail, nakhanubc@gmail.com.

    Author Contributions: Conception and design: N.A. Khan.

    Analysis and interpretation of the data: N.A. Khan.

    Drafting of the article: N. Khan.

    Critical revision for important intellectual content: N. Khan.

    Final approval of the article: N. Khan.

×
FULL TEXT
In response to SPRINT (Systolic Blood Pressure Intervention Trial), Hypertension Canada–Canadian Hypertension Education Program guidelines recommend that all patients with hypertension and high cardiovascular risk keep their systolic blood pressure (SBP) at 120 mm Hg or lower (1, 2). As more guidelines are updated, other organizations likely will advocate for more-intensive SBP targets in selected, high-risk patients. Given that the current SBP treatment goal of less than 140 mm Hg is already inadequately met, many clinicians will struggle with how to achieve the newer, more-intensive target in appropriate patients.
FULL TEXT
PDF
Not Available
Citations
Citation

Khan NA. Getting to Lower Systolic Blood Pressure: Beyond Antihypertensive Therapy. Ann Intern Med. 2016;165:661–662. doi: 10.7326/M16-1421

Download citation file:

© 2018

×
Permissions

Published: Ann Intern Med. 2016;165(9):661-662.

DOI: 10.7326/M16-1421

Published at www.annals.org on 16 August 2016

©
2016 American College of Physicians
0 Citations

Related Articles
What kind of randomized trials do patients and clinicians need?
Annals of Internal Medicine; 150 (10): JC5-2
Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial
Annals of Internal Medicine; 167 (6): 375-383
Review: Compared with systolic BP target of < 160 mm Hg, targeting < 120 is more effective; < 130 balances benefits and harms
Annals of Internal Medicine; 166 (12): JC64
Guideline: ACP and AAFP recommend systolic BP targets based on history and risk level in adults ≥ 60 years of age
Annals of Internal Medicine; 166 (8): JC38
View MoreView Less

Journal Club
What kind of randomized trials do patients and clinicians need?
Annals of Internal Medicine; 150 (10): JC5-2
Review: Compared with systolic BP target of < 160 mm Hg, targeting < 120 is more effective; < 130 balances benefits and harms
Annals of Internal Medicine; 166 (12): JC64
Guideline: ACP and AAFP recommend systolic BP targets based on history and risk level in adults ≥ 60 years of age
Annals of Internal Medicine; 166 (8): JC38
Intensive lowering of systolic BP did not reduce death or disability more than standard lowering in ICH
Annals of Internal Medicine; 165 (6): JC32
View MoreView Less

Related Topics
Cardiology
Coronary Risk Factors
Hypertension
Nephrology

Cardiology, Coronary Risk Factors, Hypertension, Nephrology.

PubMed Articles
Disparate Effects of Antibiotics on Hypertension.
Physiol Genomics 2018.
Effect of vildagliptin versus glibenclamide on endothelial function and arterial stiffness in patients with type 2 diabetes and hypertension: a randomized controlled trial.
Acta Diabetol 2018.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2018 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×